Dietary Inflammatory Potential in Young Pleople With Obesity

Launched by INSTITUTO TECNOLÓGICO Y DE ESTUDIOS SUPERIORES DE OCCIDENTE · May 6, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how the foods we eat can affect inflammation in young people who are dealing with obesity. Researchers want to understand how different dietary choices can impact health and how our bodies respond to being overweight. This is important because obesity can lead to serious health issues later in life. The study aims to gather more information on which foods might help reduce inflammation and improve overall health for young adults.

To participate in this trial, you need to be between 18 and 24 years old and have a body mass index (BMI) of 30 or higher, which means you are classified as obese. Both men and women can join, but certain conditions like pregnancy, breastfeeding, or specific health issues may exclude you. If you decide to participate, you will need to provide some samples, such as blood and diet information, to help researchers gather the necessary data. This trial has not started recruiting participants yet, so you will need to wait for further announcements if you're interested.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Both sexes with no gender exclusion
• • Age between 18 and 24 years
• • Body Mass Index (BMI) ≥ 30 kg/m²
• • Signed informed consent
• Exclusion Criteria:
• • Pregnancy or expected pregnancy within the next month
• • Women who are breastfeeding
• • Diagnosed conditions such as: diabetes mellitus, hypertension, renal or hepatic insufficiency, infectious diseases, inflammatory diseases, or any neoplastic disease
• • Conditions with dietary restrictions, such as celiac disease or history of gastric bypass surgery
• • Active alcoholism with a daily intake exceeding 50 g/day
• • Significant anticipated changes in diet or exercise within 15 days prior to the study's start
• • History of drug or medication abuse
• • Eating disorders
• • Participation in any study involving investigational products within the 3 months prior to the start of the study
• • Treatment with anti-inflammatory drugs, antibiotics, and/or antidepressants in the month prior to the study's start
• • Consumption of nutraceuticals containing prebiotics, probiotics, or immunomodulators within 15 days prior to the study's start
• • Individuals who choose to discontinue participation after the data collection process has started.
• • Individuals who do not consent to the collection of any of the required samples (blood, diet, or stool) during the data collection phase.